Literature DB >> 31545131

Redirecting the revolution: new developments in drug development for psychiatry.

Linda S Brady1, William Z Potter2, Joshua A Gordon2.   

Abstract

Entities:  

Keywords:  Autism spectrum disorder; biomarkers; bipolar disorder; major depressive disorder; psychiatric drug discovery; psychiatric genetics; public-private partnerships; schizophrenia; therapeutics; treatment-resistant depression

Mesh：

Substances：

Year:  2019        PMID： 31545131      PMCID： PMC6800004          DOI： 10.1080/17460441.2019.1666102

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN： 1746-0441            Impact factor:   6.098


× No keyword cloud information.
  11 in total

1.  2018 FDA drug approvals.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2019-02       Impact factor: 84.694

2.  Revolution stalled.

Authors:  Steven E Hyman
Journal:  Sci Transl Med       Date:  2012-10-10       Impact factor: 17.956

3.  Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model.

Authors:  Margaret C Grabb; Alan J Cross; William Z Potter; James T McCracken
Journal:  J Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.153

4.  Revitalizing psychiatric therapeutics.

Authors:  Steven E Hyman
Journal:  Neuropsychopharmacology       Date:  2014-01       Impact factor: 7.853

Review 5.  Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Dallas P Veitch; Michael W Weiner; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2018-10-13       Impact factor: 21.566

6.  Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.

Authors:  Yoonho Chung; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Sarah McEwen; Theo G M van Erp; Tyrone D Cannon
Journal:  JAMA Psychiatry       Date:  2018-09-01       Impact factor: 21.596

7.  The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development.

Authors:  Andrew D Krystal; Diego A Pizzagalli; Sanjay J Mathew; Gerard Sanacora; Richard Keefe; Allen Song; Joseph Calabrese; Andrew Goddard; Wayne Goodman; Sarah H Lisanby; Moria Smoski; Richard Weiner; Dan Iosifescu; John Nurnberger; Steven Szabo; James Murrough; Anantha Shekhar; William Potter
Journal:  Nat Rev Drug Discov       Date:  2018-12-28       Impact factor: 84.694

Review 8.  Psychiatric Genomics: An Update and an Agenda.

Authors:  Patrick F Sullivan; Arpana Agrawal; Cynthia M Bulik; Ole A Andreassen; Anders D Børglum; Gerome Breen; Sven Cichon; Howard J Edenberg; Stephen V Faraone; Joel Gelernter; Carol A Mathews; Caroline M Nievergelt; Jordan W Smoller; Michael C O'Donovan
Journal:  Am J Psychiatry       Date:  2017-10-03       Impact factor: 18.112

9.  Revealing the brain's molecular architecture.

Authors: 
Journal:  Science       Date:  2018-12-14       Impact factor: 47.728

10.  Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321
View more
  4 in total

Review 1.  The efficacy of real-time functional magnetic resonance imaging neurofeedback for psychiatric illness: A meta-analysis of brain and behavioral outcomes.

Authors:  Emily Dudek; David Dodell-Feder
Journal:  Neurosci Biobehav Rev       Date:  2020-12-25       Impact factor: 8.989

Review 2.  Promises and challenges of human computational ethology.

Authors:  Dean Mobbs; Toby Wise; Nanthia Suthana; Noah Guzmán; Nikolaus Kriegeskorte; Joel Z Leibo
Journal:  Neuron       Date:  2021-06-17       Impact factor: 18.688

Review 3.  Anxiety disorders.

Authors:  Brenda Wjh Penninx; Daniel S Pine; Emily A Holmes; Andreas Reif
Journal:  Lancet       Date:  2021-02-11       Impact factor: 202.731

4.  Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis.

Authors:  Michelle A Worthington; Elaine F Walker; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Scott W Woods; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2020-10-09       Impact factor: 4.939
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.